Use of neuromuscular blocking agents in intensive therapy practice;Utilisation des curares en réanimation

Annales Francaises d'Anesthesie et de Reanimation

Volumn 18, Issue 3, 1999, Pages 341-354

  Suppini, A ^a   Kaiser, E ^a   Sallaberry, M ^a   Colavolpe, C ^b   Pellissier, D ^b   Francois G ^b  

^a Military Teaching Hospital Sainte Anne   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Intensive therapy; Neuromuscular blockade; Neuromuscular blocking agents

Indexed keywords

CURARE; NEUROMUSCULAR BLOCKING AGENT;

ANESTHESIA; HUMAN; MEDLINE; RESUSCITATION; REVIEW;

ANESTHESIA; CURARE; HUMANS; MEDLINE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RESUSCITATION;

EID: 10644257604     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(99)80060-4     Document Type: Review

References (142)

1. e siècle de la curarisation dans le tétanos. Press Med 1965 ; 73 : 2313-7.
2. Kienlen J. Effets de l'acidose sur l'action des médicaments utilisés en anesthésie-réanimation. Ann Fr Anesth Réanim 1983 ; 2 : 280-95.
3. e Congrès national d'anesthésie et de réanimation. Paris : Masson ; 1995. p. 579-92.
4. Miller-Jones CMH, Williams JH. Sedation for ventilation. A retrospective study. Anaesthesia 1980 ; 35 : 1104-7.
5. Bion JF, Ledingham JMA. Sedation in intensive care. A postal survey. Intensive Care Med 1987 ; 13 : 215-6.
6. Suppini A, Colavolpe C, François G. Les curares en réanimation : recueil partiel de 166 fiches d'enquête [résumé]. Ann Fr Anesth Réanim 1997 ; 16 : 787.
7. Cohen AT, Kelly DR. Assessment of alfentanil by intravenous infusion as long-term sedation in intensive care. Anesthesiology 1987; 42: 545-8.
8. Pollard BJ. The use of neuromuscular blocking agents in intensive care. In: Vincent JL, ed. Yearbook of intensive care and emergency medicine. Berlin: Springer 1990. p. 749-57.
9. Isenstein DA, Venner DS, Duggan J. Neuromuscular blockade in the intensive care unit. Chest 1992 ; 102 : 1258-66.
10. Pollard BJ. Neuromuscular blocking agents in intensive care. Intensive Care Med 1993 ; 19 : S36-9.
11. Coursin DB, Prielipp RC. Use of neuromuscular blocking drugs in the critically ill patient. Crit Care Clin 1995 ; 11 : 957-81.
12. Clyburn PA, Marshall RD. Control of ventilation by continuous infusion of pancuronium bromide. Anaesthesia 1981 ; 36 : 860-2.
13. Parker MM, Schubert W, Shelhamer JH, Parillo JE. Perceptions of a critically ill patient experiencing therapeutic paralysis in an ICU. Crit Care Med 1984 ; 12 : 69-71.
14. Buck ML, Reed MD. Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients. Clin Pharm 1991 ; 10 : 32-48.
15. Klessig HT, Geiger HJ, Murray J, Coursin DB. A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle relaxants. Crit Care Med 1992 ; 20 : 1341-5.
16. Lumb PD. Sedatives and muscle relaxants in the intensive care unit. Probl Urol 1992 ; 6 : 155-73.
17. Sharpe M.D. The use of muscle relaxants in the intensive care unit. Can J Anaesth 1992 ; 39 : 949-62.
18. Coursin DB, Kelly JS, Prielipp RC. Muscle relaxants in critical care. Curr Opin Anaesth 1993 ; 6 : 341-5.
19. Elliot JM, Bion JF. The use of neuromuscular blocking drugs in intensive care practice. Acta Anaesthesiol Scand 1995 ; 106 : 70-82.
20. Meistelman C, Plaud B. Neuromuscular blockade: is it still useful in the ICU? Eur J Anaesthesiology 1997 ; 15 : 53-6.
21. Marini JJ, Rodriguez RM, Lamb V. The inspiratory work load of patient-initiated mechanical ventilation. Am Rev Respir Dis 1986 ; 134 : 902-9.
22. Murray MJ, Strickland RA, Weiler C. The use of neuromuscular blocking drugs in the intensive care unit: a US perspective. Intensive Care Med 1993 ; 19 : S40-4.
23. Darrah WC, Johnson JR, Mirakhur RK. Vecuronium infusions for prolonged muscle relaxation in the intensive care unit. Crit Care Med 1989 ; 17 : 1297-300.
24. Freebairn R, Joynt GM, Lipman J, Bothma PA. A double-blind comparison of vecuronium administered by the Springfusor infusion device to vecuronium by intermittent bolus injection in critically ill adult patients. Anaesth Intensive Care 1994 ; 22 : 580-5.
25. Sapirstein A, Hurford WE. Neuromuscular blocking agents in the managment of respiratory failure. Indications and treatment guidelines. Crit Care Clin 1994 ; 10 : 831-43.
26. Shapiro BA, Warren J, Egol AB, Greenbaum DM, Jacobi J, Nasraway SA, et al. Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Crit Care Med 1995 ; 23 : 1601-5.
27. Anonyme. Paralysed with fear [editorial]. Lancet 1981 ; 1 : 427.
28. Aitkenhead AR. Analgesia and sedation in intensive care. Br J Anaesth 1989 ; 63 : 196-206.
29. Delgado-Escueta AV, Wasterlain C, Treiman DM, Porter RJ. Management of status epilepticus. N Engl J Med 1982 ; 306 : 1337-40.
30. Mollaret P, Bastin R, Chassigneux J. État actuel du traitement du tétanos. Rev Prat 1960 ; 5 : 533-9.
31. Edmonson RS, Flowers MW. Intensive care in tetanus: management, complications and mortallity in 100 cases. Br Med J 1979; 1 : 1401-4.
32. Trujillo MJ, Castillo A, Espana JV, Guevara P, Eganez H. Tetanus in the adult: intensive care and management. Crit Care Med 1980 ; 8 : 419-23.
33. Willats SM. Paralysis for ventilated patients? Yes or no? Intensive Care Med 1985 ; 11 : 2-4.
34. Powles AB, Ganta R. Use of vecuronium in the management of tetanus. Anaesthesia 1985 ; 40 : 879-81.
35. Fassoulaki A, Eforakopoulou M. Vecuronium in the management of tetanus. Is it the muscle relaxant of choice? Acta Anaesth Belg 1988 ; 39 : 75-8.
36. Orko R, Rosenberg PH, Himberg JJ. Intravenous infusion of midazolam, propofol and vecuronium in a patient with severe tetanus. Acta Anaesthesiol Scand 1988 ; 32 : 590-2.
37. Peat SJ, Potter DR, Hunter JM. The prolonged use of atracurium in a patient with tetanus. Anaesthesia 1988 ; 43 : 962-3.
38. Rodriguez JL, Weissman C, Damask MC, Askanazi J, Hyman AI, Kinney JM. Physiological requirements during rewarming: suppression of shivering response. Crit Care Med 1983 ; 11 : 490-7.
39. Raval B, Steinberg R, Rauschkolb E. Artifact free computed tomography of the chest and abdomen in severally ill patient. J Comput Tomogr 1985 ; 9 : 9-11.
40. Roberts DJ, Clinton JE, Ruiz E. Neuromuscular blockade for critical patients in the emergency department. Ann Emerg Med 1986; 15 : 152-6.
41. Ramsay FM. Basic pharmacology of neuromuscular blocking agents. Anesth Clin North Am 1993 ; 11 : 219-36.
42. Bion JF, Bowden MI, Chow B, Honisberger L, Weatherley BC. Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation. Intensive Care Med 1993 ; 19 : S94-8.
43. Fischer DM, Canfell PC, Fahey MR, Rosen JI, Rupp SM, Sheiner LB, et al. Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organbased elimination. Anesthesiology 1986 ; 65 : 6-12.
44. Jones RM, Pearce AC, Williams JP. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium. Br J Anaesth 1984 ; 56 : 453-7.
45. Hennis PJ, Fahey MR, Canfell PC, Shi WZ, Miller RD. Pharmacology of laudanosine in dogs. Anesthesiology 1986 ; 65 : 56-60.
46. Yate PM, Flynn PJ, Arnold RW, Weatherly BC, Simmonds RJ, Dopson T. Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit. Br J Anaesth 1987 ; 59 : 211-7.
47. Parker CJR, Jones JE, Hunter JM. Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU. Br J Anaesth 1988 ; 61 : 531-40.
48. Gwinnutt CL, Eddleston JM, Edwards D, Pollard BJ. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients. Br J Anaesth 1990 ; 65 : 829-32.
49. Hunter JM. Atracurium and laudanosine pharmacokinetics in acute renal failure [abstract]. Intensive Care Med 1993 ; 19 : S91-3.
50. Prielipp RC, Coursin DB. Applied pharmacology of common neuromuscular blocking agents in critical care. New Horiz 1994 ; 2 : 34-47.
51. 2/propofol anesthesia [abstract]. Anesthesiology 1994 ; 81 : A1117.
52. Belmont MR, Lien CA, Quessy S, Abou-Donia MM, Abalos A, Eppich L, et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia [abstract]. Anesthesiology 1995 ; 82 : 1139-45.
53. Lien CA, Belmont MR, Abalos A, Eppich L, Quessy S, Abou-Donia MM, et al. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995 ; 82 : 1131-8.
54. Hunter JM, De Wolf A. The pharmacokinetics of cisatracurium in patients with renal or hepatic failure. Curr Opin Anaesth 1996 ; 9 : S42-6.
55. Eastwood NB, Boyd AH, Parker CJR, Hunter JM. Pharmacokinetics of 1R cis-1'R cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. Br J Anaesth 1995 ; 75 : 431-5.
56. Prielipp RC, Coursin DB, Scuderi PE, Bowton DL, Ford SR, Cardenas VJ, et al. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995 ; 81 : 3-12.
57. Bion J, Prielipp RC, Bihari D, Grounds M, Harper N, Hunter JM, et al. Cisatracurium in intensive care. Curr Opin Anaesth 1996 ; 9 : S47-51.
58. Boyd AH, Eastwood NB, Parker CJR, Hunter JM. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Br J Anaesth 1996; 76: 282-8.
59. Duvaldestin P, Gilbert C, Henzel D, Guy P, Desmonts JM. Pancuronium blood level monitoring in patients with tetanus. Intensive Care Med 1979 ; 5 : 111-4.
60. Kuehnl-Brady KS, Reitstätter B, Schlager A, Schreithofer D, Luger T, Seyr M, et al. Long-term administration of pancuronium and pipecuronium in the intensive care unit. Anesth Analg 1994; 78 : 1082-6.
61. Scott RPF. Autonomie and cardiovascular effects of neuromuscular blocking drugs. Curr Opin Anaesth 1992 ; 5 : 568-71.
62. Murray MJ, Coursin DB, Scuderi PE, Kamath G, Prough DS, Howard DM, et al. Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents. Crit Care Med 1995 ; 23 : 450-8.
63. Miller RD, Agoston S, Booij LHDJ, Kersen UW, Crul JF, Ham J. The comparative potency and pharmacokinetics of pancuronium and its metabolites in anesthetized man. J Pharmacol Exp Ther 1978 ; 207 : 539-43.
64. Ducharme J, Donati F. Pharmacokinetics and pharmacodynamics of steroidal muscle relaxants. Anesth Clin North Am 1993 ; 11 : 283-308.
65. Lienhart A, Guggiari M, Tauvent A, Maneglia R, Cousin MT, Viars P. Effets hémodynamiques du vecuronium chez l'homme. Ann Fr Anesth Réanim 1983 ; 2 : 7-16.
66. Segredo V, Matthay MA, Sharma ML, Gruenke LD, Caldwell JE, Miller RD. Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients. Anesthesiology 1990 ; 72 : 566-70.
67. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992 ; 327 : 524-8.
68. Wierda J, De Wit A, Kuizenga K, Agoston S. Clinical observations of the neuromuscular blocking action of Org 9426. A new steroidal non depolarising agent. Br J Anaesth 1990 ; 64 : 521-3.
69. Szenohradszky J, Fisher DM, Segredo V, Caldwell JE, Bragg P, Sharma ML, et al. Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiology 1992 ; 77 : 899-904.
70. Pollard BJ. Which drug: steroid or benzylisoquinolinium? Intensive Care Med 1993 ; 19 : S86-90.
71. Tempelhoff R, Modica PA, Jellish WS, Spitznagel EL. Resistance to atracurium-induced neuromuscular blockade in patients with extractable seizure disorders treated with anticonvulsivants. Anesth Analg 1990 ; 71 : 665-9.
72. Gooch JL, Suchyta MR, Balbierz JM, Petajan JH, Clemmer TP. Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 1991 ; 19 : 1125-31.
73. Coursin DB. Neuromuscular blockade: should patients be relaxed in the ICU? Chest 1992 ; 102 : 988-9.
74. Hansen-Flaschen J, Cowen J, Raps EC. Neuromuscular blockade in the intensive care unit. More than we bargained for. Am Rev Respir Dis 1993 ; 147 : 234-6.
75. Hoyt JW. Persistent paralysis in critically ill patients after use of neuromuscular blocking agents. New Horiz 1994 ; 2 : 48-55.
76. Giostra E, Magistris MR, Pizzolato G, Cox J, Chevrolet JC. Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Chest 1994 ; 106 : 210-20.
77. Watling SM, Dasta JF. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the litterature. Crit Care Med 1994 ; 22 : 884-93.
78. Tousignant CP, Bevan DR, Eisen AA, Fenwick JC, Tweedale MG. Acute quadripresis in an asthmatic treated with atracurium. Can J Anaesth 1995 ; 42 : 224-7.
79. Rudis MI, Guslits BJ, Peterson EL, Hathaway SJ, Angus E, Beis S, et al. Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit. Crit Care Clin 1996 ; 24 : 1749-56.
80. Prielipp RC, Coursin DB, Wood KE, Murray MJ. Complications associated with sedative and neuromuscular blocking drugs in critically ill patients. Crit Care Clin 1995 ; 11 : 983-1003.
81. Topulos GP, Lansing RW, Banzett RB. The experience of complete neuromuscular blockade in awake humans. J Clin Anesth 1993 ; 5 : 369-74.
82. Hsiang JK, Chesnut RM, Crisp CB, Klauber MR, Blunt BA, Marshall LF. Early, routine paralysis for intracranial pressure control in severe head injury: is it necessary? Crit Care Med 1994 ; 22 : 1471-6.
83. Yeaton P, Teba L. Sinus node exit block following administration of vecuronium [letter]. Anesthesiology 1988 ; 68 : 177-8.
84. Schmeling WT, Bernstein JS, Vucins EJ, Cody R. Persistent bradycardia with episodic sinus arrest after sufentanil and vecuronium administration. Successful treatment with isoproterenol. J Cardiothor Anesth 1990 ; 4 : 89-94.
85. Carter ML. Bradycardia after the use of atracurium. Br Med J 1983 ; 287 : 247-8.
86. Gronert GA, Theye RA. Physiopathology of hyperkaliemia induced by succinylcholine. Anesthesiology 1975 ; 43 : 89-99.
87. Yentis SM. Suxamethonium and hyperkaliemia. Anaesth Intensive Care 1990 ; 18 : 92-101.
88. Lee C. Suxamethonium in its fifth decade. Baillière's Clin Anaesthesiol 1994 ; 8 : 417-40.
89. Horton WA, Fergusson NV. Hyperkalaemia and cardiac arrest after the use of suxamethonium in intensive care [letter]. Anaesthesia 1988 ; 43 : 890-1.
90. Hemming AE, Charlton S, Kelly P. Hyperkalaemia, cardiac arrest, suxamethonium and intensive care [letter]. Anaesthesia 1990 ; 45 : 990-1.
91. Dornan RIP, Royston D. Suxamethonium-related hyperkalaemic cardiac arrest in intensive care [letter]. Anaesthesia 1995 ; 50 : 1006.
92. Berkahn JM, Sleigh JW. Hyperkalaemic cardiac arrest following succinylcholine in a longterm intensive care patient [letter]. Anaesth Intensive Care 1997 ; 25 : 588-9.
93. Kohlschütter B, Baur H, Roth F. Suxamethonium-induced hyperkalaemia in patients with severe intra-abdominal infections. Br J Anaesth 1976 ; 48 : 557-62.
94. Stevenson PH, Birch AA. Succinylcholine-induced hyperkalemia in a patient with a closed head injury. Anesthesiology 1979 ; 51 : 89-90.
95. Frankville DD, Drummond JC. Hyperkalemia after succinylcholine administration in a patient with closed head injury without paresis. Anesthesiology 1987 ; 67 : 264-6.
96. Schwartz DE, Kelly B, Caldwell JE, Carlisle AS, Cohen NH. Succinylcholine-induced hyperkalemic arrest in a patient with severe metabolic acidosis and exsanguinating hemorrhage. Anesth Analg 1992 ; 75 : 291-3.
97. Kovarik WD, Morray JP. Hyperkalemic cardiac arrest after succinylcholine administration in a child with purpura fulminans. Anesthesiology 1995 ; 83 : 211-3.
98. Laxenaire MC et le Groupe d'étude des réactions anaphylactoïdes peranesthésique. Substances responsables des chocs anaphylactiques peranesthésiques. Troisième enquête multicentrique française (1992-1994). Ann Fr Anesth Réanim 1996 ; 15 : 1211-8.
99. Coursin DB, Klasek G, Goelzer SL. Increased requirements for continuously infused vecuronium in critically ill patients. Anesth Analg 1989 ; 69 : 518-21.
100. Vanderheyden BA, Reynolds HN, Gerold KB, Emanuele T. Prolonged paralysis after long-term vecuronium infusion. Crit Care Med 1992 ; 20 : 304-7.
101. Dodson BA, Kelly BJ, Braswell LM, Cohen NH. Long-term, high dose muscle relaxation causes up-regulation of acetylcholine receptors in critically ill adults [abstract]. Anesthesiology 1993 ; 79 : A292.
102. Hogue CW Jr, Itani MS, Martyn JA. Resistance to d-tubocurarine in lower motor neuron injury is related to increased acetylcholine receptors at the neuromuscular junction. Anesthesiology 1990 ; 73 : 703-9.
103. Hogue CW Jr, Ward JM, Itani MS, Martyn JA. Tolerance and upregulation of acetylcholine receptors follow chronic infusion of d-tubocurarine. J Appl Physiol 1992 ; 72 : 1326-31.
104. Brett RS, Schmidt JH, Schartel SA, Poppers PJ. Measurement of acetylcholine receptor concentration in skeletal muscle from a patient with multiple sclerosis and resistance to atracurium. Anesthesiology 1987 ; 66 : 837-9.
105. Tatman AJ, Wrigley SR, Jones RM. Resistance to atracurium in a patient with an increase in plasma alpha-1 globulins. Br J Anaesth 1991 ; 67 : 623-5.
106. Badetti C, Pascal L, Bernini V, Manelli JC. Résistance au vécuronium chez le brûlé. Influence de la surface brûlée sur la dose efficace 95. Ann Fr Anesth Réanim 1996 ; 15 : 135-41.
107. Hunter JM. Resistance to non-depolarizing neuromuscular blocking agents. Br J Anaesth 1991 ; 67 : 511-4.
108. Martyn JAJ, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down regulation of skeletal muscle acetylcholine receptors: effects on neuromuscular blockers. Anesthesiology 1992; 76: 822-43.
109. Raps EC, Bird SJ, Hansen-Flaschen J. Prolonged muscle weakness after neuromuscular blockade in the intensive care unit. Crit Care Clin 1994 ; 10 : 799-813.
110. Op de Coul AA, Lambregts PC, Koeman J, van Puyenbroek MJ, Ter Laak HJ, Gabreels-Festen AA. Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 1985 ; 87 : 17-22.
111. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991 ; 14 : 1131-9.
112. Wijdicks EF, Litchy WJ, Harrisson BA, Gracey DR. The clinical spectrum of critical illness polyneuropathy. Mayo Clin Proc 1994 ; 69 : 955-9.
113. Kupfer Y, Namba T, Kaldawi E, Tessler S. Prolonged weakness after long-term infusion of vecuronium bromide. Ann Intern Med 1992 ; 15 : 484-6.
114. Meyer KC, Prielipp RC, Grossman JE, Coursin DB. Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 1994 ; 78 : 772-4.
115. Hoey LL, Joslin SM, Nahum A, Vance-Bryan K. Prolonged neuromuscular blockade in two critically ill patients treated with atracurium: electromyographic (EMG) and creatinine phosphokinase (CPK) studies. Pharmacotherapy 1995 ; 15 : 254-9.
116. MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus [letter]. Lancet 1977 ; 2 : 615.
117. Partridge BL, Abrams JH, Bazemore C, Rubin R. Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 1990 ; 18 : 1177-9.
118. Margolis BD, Khachikian D, Friedman Y, Garrard C. Prolonged reversible quadriparesis in mechanically ventilated patients who received long-term infusions of vecuronium. Chest 1991 ; 3 : 877-8.
119. Zochodne DW, Ramsay DA, Saly V, Shelley S, Moffatt S. Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994 ; 17 : 285-92.
120. Bolton CF. Neuromuscular complications of sepsis. Intensive Care Med 1993 ; 19 : S58-63.
121. Bolton CF. Muscle weakness and difficulty in weaning from the ventilator in the critical care unit. Chest 1994 ; 106 : 1-2.
122. e Journées méditerranéennes d'anesthésie-réanimation. Nice: Sauramps 1995. p. 17-32.
123. Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987 ; 110 : 819-41.
124. Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol 1993 ; 33 : 94-100.
125. Lagasse RS, Katz RI, Petersen M, Jacobson MJ, Poppers PJ. Prolonged neuromuscular blockade following vecuronium infusion. J Clin Anesth 1990 ; 2 : 269-71.
126. Coursin DB, Prielipp RC, Murray MJ. Prolonged use of neuromuscular blockers in the intensive care unit. Anesth Analg 1995 ; 80 : 643-4.
127. Miller RD. Use of neuromuscular blocking drugs in intensive care unit patients. Anesth Analg 1995 ; 81 : 1-2.
128. Smith CL, Hunter JM, Jones RS. Vecuronium infusions in patient with renal failure in an ITU. Anaesthesia 1987 ; 42 : 387-93.
129. Badetti C, Manelli JC. Curares et brûlure. Ann Fr Anesth Reanirn 1994 ; 13 : 705-12.
130. Viby-Mogensen J. Interaction of other drugs with muscle relaxants. In: Katz RL, ed. Muscle relaxants. Basic and clinical aspects. Orlando: Grune & Stratton; 1985. p. 233-56.
131. Haas JL, Shaefer MS, Miwa LJ, Wood RP, Shaw BW Jr. Prolonged paralysis associated with long-term pancuronium use. Pharmacotherapy 1989 ; 9 : 154-7.
132. Avarguès P, Cros AM, Dardel E, Darriet M, Biteau N. Intérêt du monitorage de la curarisation lors d'un bloc neuromusculaire prolongé par mivacurium. Ann Fr Anesth Réanim 1995 ; 14 : 511-3.
133. Kaiser E, Petit D, Quinot JF, Suppini A, Sallaberry M. Curarisation prolongée après mivacurium par déficit en pseudocholinestérases plasmatiques. Ann Fr Anesth Réanim 1995 ; 14 : 505-7.
134. Viggiano M, Soler C, Dumont JC, Pellissier D, François G. Bloc neuromusculaire prolongé après injection de mivacurium. Ann Fr Anesth Réanim 1995 ; 14 : 502-4.
135. Vigoureux D, Voltaire L. Curarisation prolongée après mivacurium chez une patiente traitée par cyclophosphamide. Ann Fr Anesth Réanim 1995 ; 14 : 508-10.
136. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national survey. JAMA 1991 ; 27 : 2870-5.
137. Cheng EY. The cost of sedating and paralysing the critically ill patient. Crit Care Clin 1995 ; 11 : 1005-19.
138. Russel WJ, Serie DG. Hand grip force as an assessment of recovery from neuromuscular block. J Clin Monit 1987 ; 3 : 87-9.
139. Fiamengo SA, Savarese JJ. Use of muscle relaxants in intensive care units. Crit Care Med 1991 ; 19 : 1457-9.
140. Dulin PJ, Williams CJ. Monitoring and preventive care of paralysed patient in respiratory failure. Crit Care Clin 1994 ; 10 : 815-29.
141. Rudis MI, Sikora CA, Angus E, Peterson E, Popovich J Jr, Hyzy R, et al. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromucular blocking agents in critically ill patients. Crit Care Med 1997 ; 25 : 575-83.
142. e Journées méditerranéennes d'anesthésie-réanimation. Montpellier: Sauramps; 1990. p. 95-100.